Mederi Projects Needing Funding
Together We Can Change The Treatment of Cancer And Produce Better Outcomes
Mederi Foundation has helped thousands of cancer patients enjoy productive and even cancer-free lives. Mederi offers hope and freedom over fear of a devastating cancer experience, and provides a better chance for a life fully lived.
When Mederi Medicine is implemented at the onset of a diagnosis, the possibilities of eradicating cancer are higher, probabilities of survival are drastically improved, and living a healthy, meaningful life – spiritually, mentally, and physically – is suddenly a real possibility.
The Mederi Foundation is a nonprofit organization dedicated to improving patient quality of life and outcomes in Oncology and to transforming healthcare overall. Our wholistic approach, the Eclectic Triphasic Medical System (ETMS), was developed by Mederi founder Donald Yance, and is at the forefront of leading-edge, integrative medicine, especially for people with cancer.
Giving to the Mederi Foundation supports our innovative model for cancer care, where our goal is to not only enhance people’s chances of surviving cancer, but to help them thrive. Your gift supports our commitment to whole systems research, advanced integrative oncology training for health care providers, and comprehensive patient care utilizing the Mederi Medicine model. Please help support our vision of offering hundreds of thousands of people all over the world a better chance.
Mederi’s Pioneering Programs for Advancing Personalized, Integrative Cancer Care
We provide expert guidance and deliver personalized botanical, nutritional, lifestyle, dietary, and naturopathic medicine protocols for patients through in-person or remote consults by specially trained, ETMS practitioners at Mederi Center in Ashland, Oregon.
We train health care practitioners worldwide to successfully manage a myriad of health conditions, especially cancer, through fundamental and advanced level education courses in the ETMS.
We document and publish case studies and coordinate clinical research trials with major medical institutions combining ETMS therapies with conventional medicine to validate the safety and effectiveness of using botanical and nutritional medicine in combination with standard of care treatment for improving the quality of life of people with cancer.
To optimize health, promote longevity and improve the quality of life of those facing chronic diseases, especially cancer.
To provide a comprehensive, cost-effective approach toward the transformation of healthcare for individuals and institutions.
Over the past 40 years, traditional medicine has made steady, yet slow advances in treating cancer. However, new breakthrough drugs are only extending lives by two to three months and mortality rates in Stage IV cancer have not improved. In addition, those who survive cancer often suffer debilitating symptoms from the illness itself or from the toxic treatments they undergo to fight the disease.
While there have been great discoveries in science regarding the mechanisms of cancer onset and progression, as well as targeted therapy, translating their findings into prevention and care strategies is still lagging behind. The standard course of treatment for most cancer still consists of surgery, chemotherapy, and radiation, just as it did forty years ago.
More and more people are being diagnosed with and dying from cancer each year, including children. In 2010 over 1.5 million people were diagnosed with cancer. In 2014 it is estimated that close to 1.7 million people will be diagnosed with cancer and over half a million people will die from it.
The reality is that there is no simple answer to cancer. The word “cancer” is applied to what are hundreds, perhaps even thousands of different diseases, all characterized by uncontrolled cell growth, which over time often mutates into newer, more aggressive forms of the disease. This is why a comprehensive approach is desperately needed.
There is a better way.
The Solution = The ETMS
Mederi Medicine has had astounding results, both applied singularly and in tandem with conventional cancer treatments. Most important, patients experience phenomenal results. Also, there is now a scientific basis that further substantiates the long-standing traditional and historic use of well-directed nutritional and botanical ingredients for maintaining health. These therapies, along with dietary and lifestyle interventions, including exercise and stress-reduction, and spiritual practices such as meditation, a close connection to our Creator, and positive relationships with one another, are a decidedly better way to support wellbeing and enhance quality of life and longevity.
Mederi Foundation’s ETMS gives practitioners the maps and patients the keys to achieve enhanced vitality and a greater potential for survival, to not just live longer but to thrive, in spite of cancer.
Throughout the past two decades, Clinical Master Herbalist and Certified Nutritionist Donald Yance has honed and evolved a distinctive philosophy and practical approach that merges ancient, wholistic medicine with modern, allopathic medicine—thus creating a truly integrative model that uniquely synthesizes scientific research, logic, common sense, and intuitive wisdom.
The fundamental objectives of the ETMS approach are to strengthen the individual in a harmonious way and to lessen the vulnerability to degenerative disease. In contrast to conventional medicine, where cancer is treated very generally, the ETMS is an in-depth study of a person’s illness as it is manifests uniquely in them.
In order to continue providing healthcare practitioners with ETMS training and tools, and to advance ETMS into mainstream medicine through clinical research, it is vital that four extremely important projects/plans continue moving forward.
- Grow Capacity to Offer More Patient Scholarships
Patients of any economic status should be able to receive care. There are many instances when patients come to us tapped of all their resources and unable to afford our treatment. It breaks our hearts to turn people away, which goes against our vision of providing people with care they deserve and need. With much needed help from generous donors we have provided patient scholarships. The number of cancer diagnoses is growing and, simultaneously, so is demand for our services. We need to grow this fund to continue this important program.
- The Online Education Training Program
Using online delivery allows many more health care professionals to take advantage of the effective strategies and approaches we teach.
Since 2005, Mederi Foundation has provided ETMS clinical training through multi-day intensives at our home base in Ashland, Oregon. Our in-person training programs can only accommodate a maximum of twenty-five students per session. It can be especially difficult and costly for health care professionals to take extended time away from clinical practice to travel for training. The need for this information among health care providers and their patients is obviously much greater than we can meet by continuing to offer only in-person training.
With the course in its current form, we have trained more than one-hundred practitioners, including oncologists, MDs, naturopaths, acupuncturists, herbalists, nurse practitioners, RNs, and chiropractors. Students have come from throughout the United States and Canada, as well as Scotland, Switzerland, France, Russia and Israel.
In 2013, the ETMS Clinical Training Program was delivered abroad at the Rabin Medical Center at Beilinson Hospital, the largest hospital in Tel Aviv, Israel. ETMS was presented to 150 attendees from around the region, and the integrative oncology department staff received five days of intensive training. In addition, special lectures were given to medical oncologists and dieticians.
In our effort to help practitioners gain access to continued learning and support, we’ve established an annual continuing education program for Level 2 Clinical Training Program graduates that includes a daily online network forum, weekly research updates, and monthly roundtable sessions for case presentation and discussion.
The online platform is successful in this capacity. We know the vast impact that an online training program has in reaching greater numbers of practitioners and, therefore, greater numbers of patients.
- Clinical Trials & Case Study Research
Research for developing case studies and formal clinical trials must continue in order to demonstrate ETMS as the primary integrative approach superior to other methods and practices. Ongoing research and clinical trials will help substantiate botanical medicine and nutrition as foundational therapies along with their successful use in combination with other specific targeted therapies.
Headway was made in this effort. We’ve raised $50,000 to partially fund our first clinical trial with Ohio State University’s James Cancer Center. While research has verified that people with breast cancer use complementary and integrative medicine therapies, there is no research that has studied the effect of using whole-person individualized complementary botanical, nutritional, and lifestyle therapies integrated with conventional or standard medical therapies in metastatic breast cancer. The Mederi Foundation is partnering with “The James” to conduct a preliminary study to evaluate the effects of using an established case-validated protocol (ETMS) of herbal medicines and nutritional and lifestyle therapies in personal prescriptions (timing, dosing, and combinations) along with standard or usual treatment for metastatic breast cancer.
This research initiative is of paramount importance since it will be the first prospective, randomized controlled clinical trial of its kind.
- Hire Key Leadership Positions For Long Term Sustainability
To significantly continue growth in our mission, vision and goals, we need to hire key personnel, specifically an Executive Director.
Currently, the Mederi Foundation Board is working tirelessly to move the organization’s mission forward. This year, they held their first annual retreat, signifying a deeper level of commitment from already passionate and committed leaders.
Board Member Jennifer Yance was appointed Executive Director (Gratuitous) as a temporary solution in the Foundation’s start-up phase. Now, years into our work we are realizing the long-term sustainability of the organization.
Recently, we recruited and trained our first full-time ETMS lead practitioner to provide patient services through the Centre, resulting in increased patient retention and satisfaction, improved uniformity among our practice team, and overall improved management effectiveness.
Many important structures are in place for key leadership to step in and take this organization to new heights. Now is the time to make this happen.
How We Can Move Closer to Achieving Our Vision
Though our successes to date have been significant, we still have a long way to go. We need help from passionate and visionary supporters who understand that Mederi Medicine offers the best hope for quality of life, positive outcomes, and the high probability of a better chance. Please support us in advancing personalized, integrative cancer care.
Let’s continue these four core programs:
- Patient scholarships to give more people access to this comprehensive care. Currently we are able to support only a small percentage of the people that come to us with financial need. We want to make that 75% in the first year of the campaign and achieve 100% by the third year of the campaign.
- Professional education through on-line and on-site training that will allow 30-50 % more practitioners to access ETMS training than is possible through on-site trainings alone.
- Two clinical trials and ongoing case study research that will lead the way to 21st century personalized, integrative oncology by bringing this innovative approach into the mainstream.
- Expand our leadership for the long-term, sustainable future of the organization so that we can continue providing resource information and the highest quality support services to current and future patients. We need to hire a paid Executive Director in the next two years in order to make this future possible.
Our goal is to raise $350,000 annually for the next 3 years.
For this purpose, we are launching: The Mederi Medicine Future Fund Campaign
Funds we raise through this campaign will enable the Mederi Foundation to:
- Fully fund our partially funded first clinical trial with Ohio State University’s James Cancer Center and pursue additional clinical research opportunities. Estimated annual cost: $80,000.
- Design and produce online training courses to reach 30 – 50% more practitioners which includes producing, promoting and administering the online training program. Estimated annual cost: $120,000.
- Continue offering scholarships and fund 75% of the patients in need of financial assistance.Estimated annual cost: $50,000.
- Hire key leadership for long-term sustainability, especially an Executive Director in the next two years. Estimated annual cost: $100,000.
The result? Vastly more patients helped, medical costs reduced, and better chances realized.
Please donate to the Mederi Medicine Future Fund today.